The amylin pathway slows gastric emptying through a different signaling cascade than GLP-1, and the resulting GI profile is somewhat milder
Your provider can recommend the best alternative based on your medical history and tolerance profile
Your clinical care team will work with you to identify the most affordable and suitable medication based on your health requirements and insurance coverage
According to a 2019 survey by the American Society of Plastic Surgeons (ASPS), non-surgical cosmetic procedures, including peptide therapies, witnessed a staggering 15% increase in popularity over the previous year [1]
The shortage list removal Tirzepatide was removed from the FDA drug shortage list on October 2, 2024
Eligibility is typically based on FDA-approved criteria, such as body mass index (BMI) thresholds and related health conditions, with greater flexibility under DTE models